2nd Quarter - Amendment

ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY

Firm
Client
Income
—
Expenses
$85,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 12, 2018 $85,000 Replaced
2nd Quarter - Amendment (this page) Jul 16, 2018 $85,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Submitted letter to the House Energy and Commerce Committee for the record in support of H.R. 4841 concerning standardizing electronic prior authorization for Medicare. Also sent a letter to Rep. Schweikert in support of H.R. 4841. Also sent a letter of support for H.R. 3528 for the House Energy and Commerce Committee record. H.R. 3528 provides for the e-prescribing of prescription drugs for controlled substances under Medicare Part D program. Participated in discussions on the need to address fraud, waste and abuse in the Medicare Part D program.

LobbyistCovered position, as disclosed
REGINIA GRAYSON BENJAMIN Director of Legislative Affairs
MARY JO CARDEN Vice President, Government & Pharmacy Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3528 (115th), H.R. 4841 (115th)

Pharmacy PHA

Submitted a letter to House Energy and Commerce Committee Chair and Ranking Member in support of H.R. 3545 - Overdose Prevention and Patient Safety Act. Also sent a letter for the House Energy and Commerce Committee record in support of H.R. 4275 which directs the Secretary of HHS to develop and disseminate materials, giving pharmacists the understanding and ability to decline to fill controlled substances prescriptions that are fraudulent, forged or appear to be for abuse or diversion. Sent a letter in support of S. 974, the CREATES Act to the Chairman and Ranking Member of the Senate Judiciary Committee. Dissemination of information in support of H.R. 2026 - Pharmaceutical Information Exchange Act.

LobbyistCovered position, as disclosed
REGINIA GRAYSON BENJAMIN —
MARY JO CARDEN New Vice President, Government & Pharmacy Affairs

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2026 (115th), H.R. 4275 (115th), H.R. 3545 (115th), S. 974 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.